196 related articles for article (PubMed ID: 10342043)
1. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt-Koyanagi-Harada's disease.
Uchio E; Matsumoto T; Tanaka SI; Ohno S
Clin Exp Rheumatol; 1999; 17(2):179-84. PubMed ID: 10342043
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
Srivastava MD; Rossi TM; Lebenthal E
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
[TBL] [Abstract][Full Text] [Related]
3. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.
De Rie MA; Zonneveld IM; Witkamp L; Van Lier RA; Out TA; Bos JD
Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of serum sICAM-1 and sCD4 & sCD8 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q; Xiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):596-8. PubMed ID: 15515547
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
10. Increased serum level of interleukin-33 in Vogt-Koyanagi-Harada correlates with disease activity.
Qian Y; Yu R; Zhao C; Gao F; Zhang M
Clin Immunol; 2021 Oct; 231():108846. PubMed ID: 34478883
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
Marcante R; Cavedon G
Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
[TBL] [Abstract][Full Text] [Related]
12. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Kitaichi N; Kotake S; Sasamoto Y; Namba K; Matsuda A; Ogasawara K; Onoé K; Matsuda H; Nishihira J
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):247-50. PubMed ID: 9888451
[TBL] [Abstract][Full Text] [Related]
13. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
Ohno S
Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
He Y; Wang C; Su G; Deng B; Ye Z; Huang Y; Yuan G; Aize K; Li H; Yang P
Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
[TBL] [Abstract][Full Text] [Related]
15. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
16. [Serum soluble interleukin-2 receptor levels in uveitis].
Xie C; Huang X; Zhou H; Yang P
Yan Ke Xue Bao; 1998 Jun; 14(2):64-5. PubMed ID: 12580032
[TBL] [Abstract][Full Text] [Related]
17. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity.
Alpsoy E; Cayirli C; Er H; Yilmaz E
J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596
[TBL] [Abstract][Full Text] [Related]
18. Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.
Wang C; Cao S; Zhang D; Li H; Kijlstra A; Yang P
Sci Rep; 2017 Nov; 7(1):15579. PubMed ID: 29138505
[TBL] [Abstract][Full Text] [Related]
19. Disturbed expression of Fas/FasL on CD4(+) and CD8(+)T cells in Behcet's disease, Vogt-Koyanagi-Harada syndrome, and idiopathic anterior uveitis.
Yang P; Ji L; Zhou H; Huang X; Xie C; Jin H; Chen L; Kijlstra A
Ocul Immunol Inflamm; 2001 Sep; 9(3):185-91. PubMed ID: 11815887
[TBL] [Abstract][Full Text] [Related]
20. Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.
Wang X; Zhang MF; Xie J; Li ZL; Wang P
Anat Rec (Hoboken); 2012 Jul; 295(7):1168-73. PubMed ID: 22641412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
